bioRxiv
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
bioRxiv
Jun 25, 2024, 03:11 |
Blog
Eytan Ruppin: Analyzing Tumor Microenvironment using bulk transcriptomics with Machine Learning
Eytan Ruppin, Chief of the Cancer Data Science Lab of the National Institute of Health, shared…
Apr 25, 2024, 18:50 |
Insight
Wafik S. El-Deiry: Very pleased to share bioRxiv pre-print by El-Deiry Lab member and Brown University alumnus William MacDonald
Wafik S. El-Deiry, Director of the Legorreta Cancer Center at Brown University, shared on X:…
Jan 4, 2024, 23:49 |
Blog
Allison Fitzgerald: The time between starting an R00 award and receiving a major NIH award was significantly longer for women
Allison Fitzgerald, Resident Physician at Brigham and Women's Hospital, shared the following post by bioRxiv…
Sep 24, 2023, 18:21 |
Insight
Eytan Ruppin: We present IRIS: a machine-learning method aimed at identifying candidate ligand-receptor interactions that are likely to mediate immune checkpoint blockade resistance in the tumor microenvironment.
All:
4
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube